Adma Biologics Stock Investor Sentiment

ADMA Stock  USD 21.83  0.01  0.05%   
About 64% of ADMA Biologics' investor base is looking to short. The analysis of overall sentiment of trading ADMA Biologics stock suggests that many investors are alarmed at this time. The current market sentiment, together with ADMA Biologics' historical and current headlines, can help investors time the market. In addition, many technical investors use ADMA Biologics stock news signals to limit their universe of possible portfolio assets.
  
over a month ago at investors.com         
IBD 50s Top Stock, ADMA Biologics, Crashes After Auditor Unexpectedly Resigns
Investors Business Daily at Macroaxis
over a month ago at investors.com         
How ADMA Biologics Is Changing The Bubble Boy Narrative And Dominating The IBD 50
Investors Business Daily at Macroaxis
over a month ago at gurufocus.com         
ADMA Biologics Inc Q2 2024 Earnings Call Highlights Record Revenue and Strategic Growth ...
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
Adma Biologics Stock Dips While Market Gains Key Facts
Yahoo News
over a month ago at zacks.com         
Adma Biologics Stock Dips While Market Gains Key Facts
zacks News
over a month ago at simplywall.st         
ADMA Biologics, Inc.s 27 percent Price Boost Is Out Of Tune With Revenues
Simply Wall St News at Macroaxis
over a month ago at news.google.com         
Millennium Management LLC Sells 769,366 Shares of ADMA Biologics, Inc. - MarketBeat
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Are Robust Financials Driving The Recent Rally In ADMA Biologics, Inc.s Stock?
Yahoo News
over a month ago at www.macroaxis.com         
Acquisition by Adam Grossman of 870950 shares of ADMA Biologics at 5.4 subject to Rule 16b-3
Macroaxis News
over a month ago at zacks.com         
Adma Biologics Stock Sinks As Market Gains Heres Why
zacks News
over a month ago at finance.yahoo.com         
Adma Biologics Stock Sinks As Market Gains Heres Why
Yahoo News
over a month ago at finance.yahoo.com         
Are Medical Stocks Lagging ADMA Biologics This Year?
Yahoo News
over a month ago at zacks.com         
Are Medical Stocks Lagging ADMA Biologics This Year?
zacks News
over a month ago at simplywall.st         
ADMA Biologics, Inc. is favoured by institutional owners who hold 80 percent of the company
Simply Wall St News at Macroaxis
over a month ago at zacks.com         
Disposition of 21752 shares by Adam Grossman of ADMA Biologics at 19.99 subject to Rule 16b-3
zacks News
Far too much social signal, news, headlines, and media speculation about ADMA Biologics that are available to investors today. That information is available publicly through ADMA media outlets and privately through word of mouth or via ADMA internal channels. However, regardless of the origin, that massive amount of ADMA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ADMA Biologics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ADMA Biologics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ADMA Biologics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ADMA Biologics alpha.

ADMA Biologics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for ADMA Stock analysis

When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios